NM_015087.5:c.361G>T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_015087.5(SPART):​c.361G>T​(p.Asp121Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00197 in 1,614,110 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. D121D) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0017 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0020 ( 5 hom. )

Consequence

SPART
NM_015087.5 missense

Scores

4
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:8

Conservation

PhyloP100: 1.58

Publications

3 publications found
Variant links:
Genes affected
SPART (HGNC:18514): (spartin) This gene encodes a protein containing a MIT (Microtubule Interacting and Trafficking molecule) domain, and is implicated in regulating endosomal trafficking and mitochondria function. The protein localizes to mitochondria and partially co-localizes with microtubules. Stimulation with epidermal growth factor (EGF) results in protein translocation to the plasma membrane, and the protein functions in the degradation and intracellular trafficking of EGF receptor. Multiple alternatively spliced variants, encoding the same protein, have been identified. Mutations associated with this gene cause autosomal recessive spastic paraplegia 20 (Troyer syndrome). [provided by RefSeq, Nov 2008]
SPART Gene-Disease associations (from GenCC):
  • Troyer syndrome
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0029798746).
BP6
Variant 13-36335470-C-A is Benign according to our data. Variant chr13-36335470-C-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 216688.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00167 (254/152274) while in subpopulation NFE AF = 0.00203 (138/68022). AF 95% confidence interval is 0.00175. There are 1 homozygotes in GnomAd4. There are 133 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 5 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_015087.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SPART
NM_015087.5
MANE Select
c.361G>Tp.Asp121Tyr
missense
Exon 2 of 9NP_055902.1Q8N0X7
SPART
NM_001142294.2
c.361G>Tp.Asp121Tyr
missense
Exon 2 of 9NP_001135766.1Q8N0X7
SPART
NM_001142295.2
c.361G>Tp.Asp121Tyr
missense
Exon 2 of 9NP_001135767.1Q8N0X7

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SPART
ENST00000438666.7
TSL:1 MANE Select
c.361G>Tp.Asp121Tyr
missense
Exon 2 of 9ENSP00000406061.2Q8N0X7
SPART
ENST00000451493.5
TSL:1
c.361G>Tp.Asp121Tyr
missense
Exon 2 of 9ENSP00000414147.1Q8N0X7
SPART
ENST00000494062.2
TSL:1
c.361G>Tp.Asp121Tyr
missense
Exon 3 of 10ENSP00000473599.1Q8N0X7

Frequencies

GnomAD3 genomes
AF:
0.00167
AC:
254
AN:
152156
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000410
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00915
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00203
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.00196
AC:
492
AN:
251288
AF XY:
0.00185
show subpopulations
Gnomad AFR exome
AF:
0.000554
Gnomad AMR exome
AF:
0.0000290
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00919
Gnomad NFE exome
AF:
0.00244
Gnomad OTH exome
AF:
0.000979
GnomAD4 exome
AF:
0.00200
AC:
2923
AN:
1461836
Hom.:
5
Cov.:
33
AF XY:
0.00189
AC XY:
1376
AN XY:
727218
show subpopulations
African (AFR)
AF:
0.000358
AC:
12
AN:
33480
American (AMR)
AF:
0.0000671
AC:
3
AN:
44696
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86256
European-Finnish (FIN)
AF:
0.00801
AC:
428
AN:
53410
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.00216
AC:
2403
AN:
1112000
Other (OTH)
AF:
0.00126
AC:
76
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
176
352
527
703
879
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
94
188
282
376
470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00167
AC:
254
AN:
152274
Hom.:
1
Cov.:
32
AF XY:
0.00179
AC XY:
133
AN XY:
74440
show subpopulations
African (AFR)
AF:
0.000409
AC:
17
AN:
41566
American (AMR)
AF:
0.0000654
AC:
1
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00915
AC:
97
AN:
10598
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00203
AC:
138
AN:
68022
Other (OTH)
AF:
0.000473
AC:
1
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
14
28
42
56
70
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00167
Hom.:
1
Bravo
AF:
0.000926
TwinsUK
AF:
0.00162
AC:
6
ALSPAC
AF:
0.00311
AC:
12
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00186
AC:
16
ExAC
AF:
0.00190
AC:
231
EpiCase
AF:
0.00158
EpiControl
AF:
0.00219

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
not provided (6)
-
1
-
Hereditary spastic paraplegia (1)
-
-
1
not specified (1)
-
-
1
SPART-related disorder (1)
-
1
-
Troyer syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.35
T
BayesDel_noAF
Benign
-0.27
CADD
Benign
17
DANN
Benign
0.94
DEOGEN2
Benign
0.061
T
Eigen
Benign
-0.49
Eigen_PC
Benign
-0.49
FATHMM_MKL
Benign
0.65
D
LIST_S2
Uncertain
0.87
D
M_CAP
Uncertain
0.11
D
MetaRNN
Benign
0.0030
T
MetaSVM
Benign
-0.36
T
PhyloP100
1.6
PrimateAI
Benign
0.30
T
PROVEAN
Benign
-1.5
N
REVEL
Benign
0.18
Sift
Uncertain
0.025
D
Sift4G
Uncertain
0.030
D
Polyphen
0.19
B
Vest4
0.15
MVP
0.93
MPC
0.11
ClinPred
0.012
T
GERP RS
3.1
Varity_R
0.097
gMVP
0.33
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146398746; hg19: chr13-36909607; API